{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04680065",
            "orgStudyIdInfo": {
                "id": "MSA-101"
            },
            "organization": {
                "fullName": "Brain Neurotherapy Bio, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "GDNF Gene Therapy for Multiple System Atrophy",
            "officialTitle": "Randomized, Double-Blind, Placebo-controlled Safety Study of Glial Cell Line-Derived Neurotrophic Factor Gene Transfer (AAV2-GDNF) in Multiple System Atrophy",
            "therapeuticArea": [
                "Other"
            ],
            "study": "gdnf-gene-therapy-for-multiple-system-atrophy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-12-15",
            "studyFirstSubmitQcDate": "2020-12-20",
            "studyFirstPostDateStruct": {
                "date": "2020-12-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Brain Neurotherapy Bio, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy."
        },
        "conditionsModule": {
            "conditions": [
                "Multiple System Atrophy"
            ],
            "keywords": [
                "MSA",
                "Multiple System Atrophy",
                "Neurotrophic factor",
                "Growth factor",
                "Glial cell line-derived neurotrophic factor",
                "GDNF",
                "AAV",
                "Gene therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Up to 9 study participants meeting eligibility criteria will be randomized in a 2:1 fashion to receive either the investigational medicinal product or sham surgery in this Phase 1 trial.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 9,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active Treatment",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Biological: AAV2-GDNF gene therapy"
                    ]
                },
                {
                    "label": "Placebo Surgery",
                    "type": "SHAM_COMPARATOR",
                    "interventionNames": [
                        "Procedure: Sham (Placebo) Surgery"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "AAV2-GDNF gene therapy",
                    "description": "Bilateral image-guided infusion of AAV2-GDNF into putamen, single dose",
                    "armGroupLabels": [
                        "Active Treatment"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Sham (Placebo) Surgery",
                    "description": "Bilateral partial burr/twist holes without dural penetration",
                    "armGroupLabels": [
                        "Placebo Surgery"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The incidence of Treatment-Emergent Adverse Events (TEAE) and Serious Adverse Events (SAE) assessed clinically by physical and neurological examinations",
                    "description": "Number of TEAE and SAE's reported post-treatment.",
                    "timeFrame": "3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "MSA symptoms/signs as assessed by the Unified Multiple System Atrophy Rating Scale (UMSARS)",
                    "description": "Change from baseline in the Unified Multiple System Atrophy Rating Scale (UMSARS) and compared to placebo. UMSARS total scores range from 0-104 points with higher scores indicating greater severity of impairment.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Change in striatal dopamine transporter binding as measured by [123-I] Ioflupane",
                    "description": "Percent and absolute change in ratio of specific to non-specific binding of 123I FP-CIT to DaT from baseline and compared to placebo by Single Photon Emission Computed Tomography (SPECT) dopamine transporter (DaT) imaging",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Change in the quality of life as measured by Multiple System Atrophy Quality of Life (MSA-QoL)",
                    "description": "Change from baseline and compared to placebo in the Multiple System Atrophy Quality of Life (MSA-QoL) scale. MSA-QoL is a self-reported questionnaire that measures MSA impact in day to day activities. Scale consists of 40 items with a five response option format (0 - no problem to 4 extreme problem) and a \"not applicable\" response option.",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female 35-75 years of age (inclusive)\n* Clinical diagnosis of MSA, parkinsonian type with symptoms onset sporadic, progressive and \\> 30 years of age\n* Less than 5 years from MSA parkinsonian diagnosis with expected survival more than 3 years\n* Stable anti-parkinsonian medication regimen\n* Ability to walk a distance of 25 feet with or without an assistive device\n\nExclusion Criteria:\n\n* Presence of idiopathic Parkinson's disease (PD) or any PD-related mutation or other neurological diseases\n* Presence of dementia, psychosis, substance abuse or poorly controlled depression\n* Prior brain surgery (i.e., deep brain stimulator implantation) or other brain imaging abnormalities\n* History of cancer or poorly controlled medical conditions that would increase surgical risk\n* Received investigational agent within 12 weeks\n* Inability to tolerate laying flat in an MRI and/or allergy to gadolinium\n\nNOTE: Other protocol defined Inclusion/Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "35 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Akash Pandhare, MD",
                    "role": "CONTACT",
                    "phone": "336-265-2790",
                    "email": "askfirst@askbio.com"
                },
                {
                    "name": "Christian Urrea, MD",
                    "role": "CONTACT",
                    "phone": "336-265-2790",
                    "email": "askfirst@askbio.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of California Irvine",
                    "status": "RECRUITING",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92697",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sally Alcocer",
                            "role": "CONTACT",
                            "phone": "949-824-3990",
                            "email": "GDNFMSA@hs.uci.edu"
                        },
                        {
                            "name": "Nicolas Phielipp, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                },
                {
                    "facility": "Parkinson's Disease and Movement Disorders Center of Boca Raton",
                    "status": "RECRUITING",
                    "city": "Boca Raton",
                    "state": "Florida",
                    "zip": "33486",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lauren Salmon",
                            "role": "CONTACT",
                            "email": "info@parkinsonscenter.org"
                        },
                        {
                            "name": "Stuart H. Isaacson, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.3669,
                        "lon": -80.13033
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Quest Research Institute",
                    "status": "RECRUITING",
                    "city": "Farmington Hills",
                    "state": "Michigan",
                    "zip": "48334",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Renee Najor",
                            "role": "CONTACT",
                            "email": "Renee.Najor@questri.com"
                        },
                        {
                            "name": "Aaron Ellenbogen, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.48531,
                        "lon": -83.37716
                    }
                },
                {
                    "facility": "The Ohio State University Medical Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Nurse Navigator Service for Potential Participants",
                    "url": "https://mytomorro.ws/msa-101-gov"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019578",
                    "term": "Multiple System Atrophy"
                },
                {
                    "id": "D000012791",
                    "term": "Shy-Drager Syndrome"
                },
                {
                    "id": "D000001284",
                    "term": "Atrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000054969",
                    "term": "Primary Dysautonomias"
                },
                {
                    "id": "D000001342",
                    "term": "Autonomic Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000080874",
                    "term": "Synucleinopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000007022",
                    "term": "Hypotension"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "asFound": "Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21514",
                    "name": "Multiple System Atrophy",
                    "asFound": "Multiple System Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15597",
                    "name": "Shy-Drager Syndrome",
                    "asFound": "Multiple System Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M4643",
                    "name": "Autonomic Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27979",
                    "name": "Primary Dysautonomias",
                    "relevance": "LOW"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M2217",
                    "name": "Synucleinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10072",
                    "name": "Hypotension",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3956",
                    "name": "Multiple System Atrophy",
                    "asFound": "Multiple System Atrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}